Hepatitis C

Screening and treatment of Hep C.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Infectious DiseasesHepatology

Clinical Guidelines

CKS: Hepatitis C
National
Glecaprevir–pibrentasvir for treating chronic hepatitis C | NICE TA499
National
SIGN 133 • Management of hepatitis C
National
2017 KASL Clinical Practice Guidelines Management of Hepatitis C
Local
AAFP: Hepatitis C: Diagnosis and Management
Local
AASLD Practice Guideline: Hepatitis C
Local
ACOG Clinical Practice Guideline No. 6: Viral Hepatitis in Pregnancy
Local
ACP Best Practice Advice on Treatment of Hepatitis C Virus Infection
Local
AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis C Virus Reactivation During Immunosuppressive Drug Therapy
Local
APASL Consensus Statements and Recommendation on Treatment of Hepatitis C Virus Infection
Local
APASL Consensus Statements and Recommendations for Hepatitis C Prevention, Epidemiology, and Laboratory Testing
Local
Australian Recommendations for the Management of Hepatitis C Virus Infection: A Consensus Statement 2022
Local
CDC: Clinical Screening and Diagnosis for Hepatitis C
Local
Clinical Practice Guidance for Testing, Managing, and Treating Hepatitis C
Local
EASL Recommendations on Treatment of Hepatitis C: Final Update of the Series
Local
HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
Local
Hepatitis C Virus Screening, Testing, and Diagnosis in Adults
Local
Hepatitis C Virus/HIV Coinfection | NIH HIV Clinical Guidelines
Local
KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease
Local
Society for Maternal-Fetal Medicine Consult Series #56: Hepatitis C in Pregnancy
Local
USPSTF Recommendation: Hepatitis C Virus Infection in Adolescents and Adults: Screening
Local
World Health Organization Guidelines on Treatment of Hepatitis C
Local